Widmann Financial Services’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$427K Sell
2,167
-2
-0.1% -$386 0.25% 76
2025
Q4
$399K Sell
2,169
-7
-0.3% -$1.23K 0.24% 77
2025
Q3
$334K Hold
2,176
0.21% 85
2025
Q2
$304K Buy
2,176
+258
+13% +$36.2K 0.21% 87
2025
Q1
$282K Buy
1,918
+75
+4% +$10.9K 0.22% 82
2024
Q4
$242K Buy
1,843
+37
+2% +$5.18K 0.19% 87
2024
Q3
$281K Buy
1,806
+200
+12% +$32.3K 0.21% 84
2024
Q2
$250K Buy
+1,606
New +$242K 0.2% 84
2022
Q1
Sell
-672
Closed -$78K 112
2021
Q4
$78K Buy
+672
New +$79.1K 0.06% 139

Other funds holding AZN

Widmann Financial Services's AZN Position: Q1 2026 in Review

Widmann Financial Services reduced its AstraZeneca (AZN) stake by 0.09% in Q1 2026, selling an estimated $386 and leaving 2,167 shares worth $427K. The position accounts for 0.25% of the portfolio, ranked #76.

Widmann Financial Services first reported a position in AZN in Q4 2021 and has held it in 9 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Widmann Financial Services held 2,167 shares of AstraZeneca worth $427K as of Q1 2026.
  • Widmann Financial Services sold 2 AstraZeneca shares in Q1 2026, an estimated $386.
  • AstraZeneca made up 0.25% of Widmann Financial Services's portfolio in Q1 2026, its #76 holding.
  • Widmann Financial Services first reported a position in AstraZeneca in Q4 2021 and has held it in 9 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Widmann Financial Services's 13F filing for Q1 2026, filed 15 May 2026.